Concepedia

John J. Flanagan

JJ

3

Publications

299

Citations

3

H-Index

2000

Active since

Affiliations

Dana-Farber Cancer Institute(Current)

John J. Flanagan is an author at Dana-Farber Cancer Institute specializing in metabolic syndrome, urology, and diabetes.

ORCID

Top concepts

Publications per year

2000–2024

3

Publications

3

Oral Estrogen Receptor PROTAC Vepdegestrant (ARV-471) Is Highly Efficacious as Monotherapy and in Combination with CDK4/6 or PI3K/mTOR Pathway Inhibitors in Preclinical ER+ Breast Cancer Models

Sheryl M. Gough, John J. Flanagan, Jessica L.F. Teh et al. · Clinical Cancer Research · 2024 · 120 citations · Full text

Work‐Based Learning as a means of developing and assessing nursing competence

John J. Flanagan, Susan Baldwin, David Clarke · Journal of Clinical Nursing · 2000 · 106 citations

, , +13

Presence of the metabolic syndrome is associated with shorter time to castration-resistant prostate cancer

John J. Flanagan, Peggy Gray, Noah M. Hahn et al. · Annals of Oncology · 2010 · 73 citations · Full text

, , +13

Rows per page

1–3 of 3